Dielectrophoresis enrichment with built-in capacitive sensor microfluidic platform for tumor rare cell detection
This paper presents a dielectrophoresis (DEP) enrichment microfluidic platform with built-in
anti-bodybased capacitive sensor for tumor rare cells detection. We take the advantages of
the effective DEP actuation, the high selectivity property of antibody for rare cell
immobilization, and the high sensitivity of differential capacitive sensing for quantitatively
reading out, to produce advanced platform, toward single tumor cell detection for the rapid
laboratory tests of cancers diagnoses and other metabolic diseases applications.
anti-bodybased capacitive sensor for tumor rare cells detection. We take the advantages of
the effective DEP actuation, the high selectivity property of antibody for rare cell
immobilization, and the high sensitivity of differential capacitive sensing for quantitatively
reading out, to produce advanced platform, toward single tumor cell detection for the rapid
laboratory tests of cancers diagnoses and other metabolic diseases applications.
Dielectrophoresis enrichment with built-in capacitive sensor microfluidic platform for tumor rare cell detection
This paper presents a dielectrophoresis (DEP) enrichment microfluidic platform with built-in
anti-bodybased capacitive sensor for tumor rare cells detection. We take the advantages of
the effective DEP actuation, the high selectivity property of antibody for rare cell
immobilization, and the high sensitivity of differential capacitive sensing for quantitatively
reading out, to produce advanced platform, toward single tumor cell detection for the rapid
laboratory tests of cancers diagnoses and other metabolic diseases applications.
anti-bodybased capacitive sensor for tumor rare cells detection. We take the advantages of
the effective DEP actuation, the high selectivity property of antibody for rare cell
immobilization, and the high sensitivity of differential capacitive sensing for quantitatively
reading out, to produce advanced platform, toward single tumor cell detection for the rapid
laboratory tests of cancers diagnoses and other metabolic diseases applications.